Prostate cancer Board decisions

The Board finds that currently diagnosed prostate cancer is not caused or permanently worsened in severity by the service-connected basal cell cancer.

The Veteran's prostate cancer was not incurred or aggravated during his active service, and the Board finds that there is no evidence of exposure to herbicides. As a result, the claim for service connection for prostate cancer is denied.

The Board has determined that the Veteran's claim for service connection for prostate cancer cannot be reopened as there is no new and material evidence to support it.

The Board found that the Veteran's fatal prostate cancer was not attributable to his active military service, including in-service exposure to ionizing radiation.

The Board has remanded the case for further development, including obtaining medical opinions regarding the Veteran's spinal cord injury and prostate cancer, as well as arranging for VA examinations to assess the severity of these conditions.

The Veteran's claim for service connection for prostate cancer, with residuals of erectile dysfunction and incontinence, to include as due to Agent Orange exposure, is being remanded for additional development.

The Board has ordered a remand to obtain an adequate VA examination and medical opinion regarding the etiology of the Veteran's prostate cancer and erectile dysfunction, as well as whether these conditions are related to his service-connected BPH/prostatitis.

The Veteran's appeal is remanded for further development, including obtaining additional medical records and scheduling a VA examination. The RO will also consider whether referral of the claim to the Under Secretary for Benefits or the Director of Compensation and Pension for consideration of an extraschedular award is warranted.

The Veteran's prostate cancer is being reviewed due to his participation in Project Crested Ice, a recovery operation of B-52 wreckage. The RO has not referred the case for a radiation dose estimate as required by VA regulations.

The Veteran's prostate cancer is presumed to have been incurred in service as a result of herbicide exposure, which represents a complete grant of the Veteran's claim.

The Board has determined that a VA examination and opinion are needed to determine the nature and etiology of the Veteran's prostate cancer, as well as whether his exposure to chemicals or asbestosis during service is related to his condition. The case will be remanded for these actions.

The Veteran's TDIU claim is being remanded for additional development, including obtaining VA and private medical records, as well as scheduling a VA examination to assess his employability due to service-connected disabilities.

The Board has requested a medical opinion regarding the etiology of the Veteran's prostate cancer. The case is being remanded to allow for further review and consideration of the new evidence submitted by the Veteran.

The Veteran's claim for service connection for prostate cancer, claimed as due to exposure to herbicides, is being remanded for additional development.

The Board has reopened the Veteran's claim for service connection of prostate cancer and granted it, finding that new evidence supports a theory of service connection secondary to herbicide exposure. The Veteran currently has prostate cancer and was exposed to herbicides in Thailand during his active duty.

The Board has remanded the Veteran's TDIU claim due to insufficient evidence regarding his combined service-connected disabilities and their impact on employment, as well as for referral of the issue to the Director of VA's Compensation and Pension Service.

The Board has granted a 60 percent rating for the Veteran's service-connected residuals of prostate cancer, but denied his request for an increased rating. A separate 10 percent rating was assigned for the Veteran's postoperative scar from June 26, 2012.

The Board denied service connection for type II diabetes mellitus and prostate cancer residuals as the Veteran did not have these conditions to a compensable degree within one year of separation from service.

The Board finds that the Veteran's prostate cancer is not related to his military service, including any exposure to DDT or benzene.

The Veteran's prostate cancer post radical prostatectomy is currently rated at 40 percent effective August 1, 2010. The condition manifests as urinary frequency of four to five times per night.